Childhood obesity and multiple sclerosis: A Mendelian randomization study
- PMID: 33749377
- DOI: 10.1177/13524585211001781
Childhood obesity and multiple sclerosis: A Mendelian randomization study
Abstract
Background: Higher childhood body mass index (BMI) has been associated with an increased risk of multiple sclerosis (MS).
Objective: To evaluate whether childhood BMI has a causal influence on MS, and whether this putative effect is independent from early adult obesity and pubertal timing.
Methods: We performed Mendelian randomization (MR) using summary genetic data on 14,802 MS cases and 26,703 controls. Large-scale genome-wide association studies provided estimates for BMI in childhood (n = 47,541) and adulthood (n = 322,154). In multivariable MR, we examined the direct effects of each timepoint and further adjusted for age at puberty. Findings were replicated using the UK Biobank (n = 453,169).
Results: Higher genetically predicted childhood BMI was associated with increased odds of MS (odds ratio (OR) = 1.26/SD BMI increase, 95% confidence interval (CI): 1.07-1.50). However, there was little evidence of a direct effect after adjusting for adult BMI (OR = 1.03, 95% CI: 0.70-1.53). Conversely, the effect of adult BMI persisted independent of childhood BMI (OR = 1.43; 95% CI: 1.01-2.03). The addition of age at puberty did not alter the findings. UK Biobank analyses showed consistent results. Sensitivity analyses provided no evidence of pleiotropy.
Conclusion: Genetic evidence supports an association between childhood obesity and MS susceptibility, mediated by persistence of obesity into early adulthood but independent of pubertal timing.
Keywords: Mendelian randomization; Multiple sclerosis; genetic epidemiology; obesity.
Similar articles
-
Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study.Neurology. 2019 Apr 16;92(16):e1803-e1810. doi: 10.1212/WNL.0000000000007325. Epub 2019 Mar 20. Neurology. 2019. PMID: 30894442 Free PMC article.
-
Timing of Pubertal Development and Midlife Blood Pressure in Men and Women: A Mendelian Randomization Study.J Clin Endocrinol Metab. 2022 Jan 1;107(1):e386-e393. doi: 10.1210/clinem/dgab561. J Clin Endocrinol Metab. 2022. PMID: 34343299
-
Reassessing the causal role of obesity in breast cancer susceptibility: a comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure.Int J Epidemiol. 2023 Feb 8;52(1):58-70. doi: 10.1093/ije/dyac143. Int J Epidemiol. 2023. PMID: 35848946 Free PMC article.
-
Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.Hum Reprod. 2023 Jun 1;38(6):1168-1182. doi: 10.1093/humrep/dead053. Hum Reprod. 2023. PMID: 37015099 Free PMC article.
-
Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies.Mult Scler. 2020 Apr;26(4):397-404. doi: 10.1177/1352458519872664. Epub 2019 Sep 6. Mult Scler. 2020. PMID: 32249718 Review.
Cited by
-
A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.J Neuroimmunol. 2023 Jun 15;379:578105. doi: 10.1016/j.jneuroim.2023.578105. Epub 2023 May 11. J Neuroimmunol. 2023. PMID: 37207441 Free PMC article.
-
Dissecting shared genetic architecture between obesity and multiple sclerosis.EBioMedicine. 2023 Jul;93:104647. doi: 10.1016/j.ebiom.2023.104647. Epub 2023 Jun 8. EBioMedicine. 2023. PMID: 37300932 Free PMC article.
-
Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study.Neurol Neuroimmunol Neuroinflamm. 2022 Apr 7;9(3):e1165. doi: 10.1212/NXI.0000000000001165. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35393342 Free PMC article.
-
Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.J Alzheimers Dis. 2023;93(1):263-273. doi: 10.3233/JAD-221007. J Alzheimers Dis. 2023. PMID: 37005885 Free PMC article. Clinical Trial.
-
The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review.J Pers Med. 2023 Oct 24;13(11):1524. doi: 10.3390/jpm13111524. J Pers Med. 2023. PMID: 38003839 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical